Matches in Nanopublications for { ?s ?p "[Four tyrosine kinase inhibitors that have activity against KIT are currently being used in clinical trials, and one, STI571, has recently been approved by the United States Food and Drug Administration for treating patients with chronic myelogenous leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP226524.RAkuy-yqLcbSAGJivrbv60jwdYQKtEgn52YGRVO2Di_sM130_assertion description "[Four tyrosine kinase inhibitors that have activity against KIT are currently being used in clinical trials, and one, STI571, has recently been approved by the United States Food and Drug Administration for treating patients with chronic myelogenous leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226524.RAkuy-yqLcbSAGJivrbv60jwdYQKtEgn52YGRVO2Di_sM130_provenance.
- NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_assertion description "[Four tyrosine kinase inhibitors that have activity against KIT are currently being used in clinical trials, and one, STI571, has recently been approved by the United States Food and Drug Administration for treating patients with chronic myelogenous leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_provenance.
- NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_assertion description "[Four tyrosine kinase inhibitors that have activity against KIT are currently being used in clinical trials, and one, STI571, has recently been approved by the United States Food and Drug Administration for treating patients with chronic myelogenous leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_provenance.
- assertion description "[Four tyrosine kinase inhibitors that have activity against KIT are currently being used in clinical trials, and one, STI571, has recently been approved by the United States Food and Drug Administration for treating patients with chronic myelogenous leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.